Diagnostic and therapeutic technology assessment. Immunoaugmentative therapy.
The scientific evidence to date, as well as the history of IAT, will allow no other conclusion than that IAT is unequivocally dangerous to its patients and of no proved value as a treatment for cancer. Physicians who know of patients receiving IAT must be aware of the high risk those people are incurring for life-threatening infections of several types.
D000574:American Medical Association; D000529:Complementary Therapies; D004340:Drug Contamination; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods*; D009369:Neoplasms / Q000628:therapy*; D013673:Technology Assessment, Biomedical; D014481:United States